nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—type 1 diabetes mellitus	0.848	1	CbGaD
Niclosamide—STAT3—islet of Langerhans—type 1 diabetes mellitus	0.0037	0.18	CbGeAlD
Niclosamide—STAT3—retina—type 1 diabetes mellitus	0.00317	0.154	CbGeAlD
Niclosamide—STAT3—nephron tubule—type 1 diabetes mellitus	0.00298	0.145	CbGeAlD
Niclosamide—STAT3—cardiovascular system—type 1 diabetes mellitus	0.00268	0.13	CbGeAlD
Niclosamide—STAT3—kidney—type 1 diabetes mellitus	0.00262	0.127	CbGeAlD
Niclosamide—STAT3—pancreas—type 1 diabetes mellitus	0.0026	0.126	CbGeAlD
Niclosamide—STAT3—lymphoid tissue—type 1 diabetes mellitus	0.00225	0.109	CbGeAlD
Niclosamide—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000601	0.0292	CbGeAlD
Niclosamide—STAT3—IL23-mediated signaling events—TNF—type 1 diabetes mellitus	0.000335	0.00255	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL2RA—type 1 diabetes mellitus	0.000333	0.00253	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by TCPTP—EGFR—type 1 diabetes mellitus	0.000331	0.00251	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—VAV1—type 1 diabetes mellitus	0.000318	0.00241	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—VAV1—type 1 diabetes mellitus	0.000316	0.0024	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IL1B—type 1 diabetes mellitus	0.000314	0.00239	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IL2—type 1 diabetes mellitus	0.000313	0.00238	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—E2F1—type 1 diabetes mellitus	0.000312	0.00237	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—IGF1—type 1 diabetes mellitus	0.000311	0.00236	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—NOS3—type 1 diabetes mellitus	0.000309	0.00235	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—CD86—type 1 diabetes mellitus	0.000308	0.00234	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—CDK4—type 1 diabetes mellitus	0.000302	0.00229	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PDX1—type 1 diabetes mellitus	0.000296	0.00225	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—HNF1A—type 1 diabetes mellitus	0.000296	0.00225	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—VAV1—type 1 diabetes mellitus	0.000295	0.00224	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—CASP3—type 1 diabetes mellitus	0.000294	0.00223	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—ITPR3—type 1 diabetes mellitus	0.000293	0.00223	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—CASP3—type 1 diabetes mellitus	0.00029	0.00221	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—VAV1—type 1 diabetes mellitus	0.000288	0.00219	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—ERBB3—type 1 diabetes mellitus	0.000278	0.00211	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—CD86—type 1 diabetes mellitus	0.000277	0.00211	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PTPN2—type 1 diabetes mellitus	0.000271	0.00206	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IL6—type 1 diabetes mellitus	0.000271	0.00206	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by PTP1B—EGFR—type 1 diabetes mellitus	0.000268	0.00204	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—B2M—type 1 diabetes mellitus	0.000268	0.00204	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—IL1B—type 1 diabetes mellitus	0.000263	0.002	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—E2F1—type 1 diabetes mellitus	0.000262	0.00199	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—VAV1—type 1 diabetes mellitus	0.000261	0.00198	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.00026	0.00197	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—CD4—type 1 diabetes mellitus	0.00026	0.00197	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CD86—type 1 diabetes mellitus	0.000257	0.00195	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CD86—type 1 diabetes mellitus	0.000251	0.00191	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—ERBB3—type 1 diabetes mellitus	0.00025	0.0019	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TNF—type 1 diabetes mellitus	0.000248	0.00188	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—IL6—type 1 diabetes mellitus	0.00024	0.00182	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—type 1 diabetes mellitus	0.000238	0.00181	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DPB1—type 1 diabetes mellitus	0.000237	0.0018	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTSH—type 1 diabetes mellitus	0.000236	0.0018	CbGpPWpGaD
Niclosamide—STAT3—Immune System—OAS1—type 1 diabetes mellitus	0.000236	0.0018	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—TYK2—type 1 diabetes mellitus	0.000235	0.00178	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—E2F1—type 1 diabetes mellitus	0.000234	0.00178	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-E—type 1 diabetes mellitus	0.000233	0.00177	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—ERBB3—type 1 diabetes mellitus	0.000232	0.00176	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CD86—type 1 diabetes mellitus	0.000227	0.00173	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—INS—type 1 diabetes mellitus	0.000227	0.00172	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—ERBB3—type 1 diabetes mellitus	0.000226	0.00172	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—CD80—type 1 diabetes mellitus	0.000225	0.00171	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—IL6—type 1 diabetes mellitus	0.000223	0.0017	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—IL6—type 1 diabetes mellitus	0.000223	0.0017	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—EGFR—type 1 diabetes mellitus	0.000222	0.00168	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IGF1—type 1 diabetes mellitus	0.000219	0.00167	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—EGFR—type 1 diabetes mellitus	0.000219	0.00166	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—ERBB3—type 1 diabetes mellitus	0.000205	0.00156	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—VAV1—type 1 diabetes mellitus	0.000204	0.00155	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—CD80—type 1 diabetes mellitus	0.000202	0.00154	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—TNF—type 1 diabetes mellitus	0.000201	0.00153	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—VAV1—type 1 diabetes mellitus	0.000201	0.00152	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DQA1—type 1 diabetes mellitus	0.000198	0.0015	CbGpPWpGaD
Niclosamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000197	0.0015	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL1B—type 1 diabetes mellitus	0.000196	0.00149	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL2—type 1 diabetes mellitus	0.000195	0.00148	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CAT—type 1 diabetes mellitus	0.000194	0.00147	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDK4—type 1 diabetes mellitus	0.000191	0.00145	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—TYK2—type 1 diabetes mellitus	0.00019	0.00144	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CD80—type 1 diabetes mellitus	0.000187	0.00142	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DQB1—type 1 diabetes mellitus	0.000185	0.0014	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—SOD2—type 1 diabetes mellitus	0.000184	0.0014	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CD80—type 1 diabetes mellitus	0.000183	0.00139	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD226—type 1 diabetes mellitus	0.000179	0.00136	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNGR2—type 1 diabetes mellitus	0.000179	0.00136	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000177	0.00135	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—E2F1—type 1 diabetes mellitus	0.000177	0.00135	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CD86—type 1 diabetes mellitus	0.000175	0.00133	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—EGFR—type 1 diabetes mellitus	0.000174	0.00133	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TNF—type 1 diabetes mellitus	0.000174	0.00132	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—TYK2—type 1 diabetes mellitus	0.000171	0.0013	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000168	0.00128	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—NOS3—type 1 diabetes mellitus	0.000167	0.00127	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-B—type 1 diabetes mellitus	0.000166	0.00126	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CD80—type 1 diabetes mellitus	0.000166	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—TYK2—type 1 diabetes mellitus	0.000158	0.0012	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—ERBB3—type 1 diabetes mellitus	0.000158	0.0012	CbGpPWpGaD
Niclosamide—Diflunisal—ALB—type 1 diabetes mellitus	0.000156	0.658	CrCbGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2RA—type 1 diabetes mellitus	0.000156	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Disease—G6PC2—type 1 diabetes mellitus	0.000155	0.00118	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000155	0.00118	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.000155	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—TYK2—type 1 diabetes mellitus	0.000155	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-A—type 1 diabetes mellitus	0.000154	0.00117	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—EGFR—type 1 diabetes mellitus	0.000153	0.00116	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDK4—type 1 diabetes mellitus	0.000144	0.0011	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DRB1—type 1 diabetes mellitus	0.000141	0.00107	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—TYK2—type 1 diabetes mellitus	0.00014	0.00106	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000136	0.00103	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000133	0.00101	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CBLB—type 1 diabetes mellitus	0.000131	0.000999	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CD80—type 1 diabetes mellitus	0.000128	0.00097	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000124	0.000945	CbGpPWpGaD
Niclosamide—STAT3—Immune System—SELL—type 1 diabetes mellitus	0.000124	0.000943	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TNF—type 1 diabetes mellitus	0.000123	0.000932	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1R1—type 1 diabetes mellitus	0.000121	0.000919	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—EGFR—type 1 diabetes mellitus	0.000121	0.000918	CbGpPWpGaD
Niclosamide—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.00012	0.000913	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL6—type 1 diabetes mellitus	0.000117	0.000893	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL6—type 1 diabetes mellitus	0.000115	0.000873	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—TYK2—type 1 diabetes mellitus	0.00011	0.000833	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—EGFR—type 1 diabetes mellitus	0.000109	0.000825	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—EGFR—type 1 diabetes mellitus	0.000108	0.000821	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.000108	0.000819	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IFNG—type 1 diabetes mellitus	0.000103	0.00078	CbGpPWpGaD
Niclosamide—STAT3—Immune System—LGALS3—type 1 diabetes mellitus	0.000102	0.000775	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—EGFR—type 1 diabetes mellitus	0.000101	0.000765	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—type 1 diabetes mellitus	9.9e-05	0.000753	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—EGFR—type 1 diabetes mellitus	9.84e-05	0.000748	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ITPR3—type 1 diabetes mellitus	9.74e-05	0.00074	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFIH1—type 1 diabetes mellitus	9.67e-05	0.000735	CbGpPWpGaD
Niclosamide—STAT3—Disease—SLC11A1—type 1 diabetes mellitus	9.42e-05	0.000716	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—type 1 diabetes mellitus	9.28e-05	0.000705	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL1B—type 1 diabetes mellitus	9.15e-05	0.000696	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2—type 1 diabetes mellitus	9.12e-05	0.000693	CbGpPWpGaD
Niclosamide—STAT3—Disease—ITPR3—type 1 diabetes mellitus	8.99e-05	0.000683	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CASP3—type 1 diabetes mellitus	8.98e-05	0.000682	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	8.91e-05	0.000678	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTPN2—type 1 diabetes mellitus	8.85e-05	0.000672	CbGpPWpGaD
Niclosamide—STAT3—Immune System—B2M—type 1 diabetes mellitus	8.75e-05	0.000665	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CDK4—type 1 diabetes mellitus	8.74e-05	0.000664	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOC3—type 1 diabetes mellitus	8.41e-05	0.000639	CbGpPWpGaD
Niclosamide—STAT3—Disease—IAPP—type 1 diabetes mellitus	8.41e-05	0.000639	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—type 1 diabetes mellitus	8.34e-05	0.000634	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	8.22e-05	0.000625	CbGpPWpGaD
Niclosamide—Clonazepam—ALB—type 1 diabetes mellitus	8.09e-05	0.342	CrCbGaD
Niclosamide—STAT3—Disease—B2M—type 1 diabetes mellitus	8.08e-05	0.000614	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—INS—type 1 diabetes mellitus	7.79e-05	0.000592	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	7.74e-05	0.000588	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DPB1—type 1 diabetes mellitus	7.73e-05	0.000588	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-E—type 1 diabetes mellitus	7.61e-05	0.000578	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—type 1 diabetes mellitus	7.57e-05	0.000575	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	7.56e-05	0.000574	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GAL—type 1 diabetes mellitus	7.55e-05	0.000573	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL20—type 1 diabetes mellitus	7.46e-05	0.000567	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL11—type 1 diabetes mellitus	7.46e-05	0.000567	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—type 1 diabetes mellitus	7.43e-05	0.000565	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTLA4—type 1 diabetes mellitus	7.33e-05	0.000557	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	7.02e-05	0.000534	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	7.02e-05	0.000533	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD79A—type 1 diabetes mellitus	6.99e-05	0.000531	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TYK2—type 1 diabetes mellitus	6.96e-05	0.000529	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PRKCQ—type 1 diabetes mellitus	6.86e-05	0.000522	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—EGFR—type 1 diabetes mellitus	6.86e-05	0.000521	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	6.85e-05	0.000521	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS1—type 1 diabetes mellitus	6.77e-05	0.000514	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	6.74e-05	0.000512	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	6.72e-05	0.00051	CbGpPWpGaD
Niclosamide—STAT3—Immune System—VAV1—type 1 diabetes mellitus	6.67e-05	0.000507	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DQA1—type 1 diabetes mellitus	6.45e-05	0.00049	CbGpPWpGaD
Niclosamide—STAT3—Disease—PRKCQ—type 1 diabetes mellitus	6.34e-05	0.000482	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	6.3e-05	0.000479	CbGpPWpGaD
Niclosamide—STAT3—Disease—VAV1—type 1 diabetes mellitus	6.15e-05	0.000468	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DQB1—type 1 diabetes mellitus	6.04e-05	0.000459	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	5.93e-05	0.00045	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOC3—type 1 diabetes mellitus	5.89e-05	0.000448	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IAPP—type 1 diabetes mellitus	5.89e-05	0.000448	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD86—type 1 diabetes mellitus	5.81e-05	0.000442	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD40LG—type 1 diabetes mellitus	5.7e-05	0.000433	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—type 1 diabetes mellitus	5.64e-05	0.000428	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—type 1 diabetes mellitus	5.62e-05	0.000427	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-B—type 1 diabetes mellitus	5.42e-05	0.000412	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD86—type 1 diabetes mellitus	5.37e-05	0.000408	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	5.36e-05	0.000407	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—type 1 diabetes mellitus	5.27e-05	0.0004	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERBB3—type 1 diabetes mellitus	5.24e-05	0.000398	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SST—type 1 diabetes mellitus	5.17e-05	0.000393	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	5.15e-05	0.000391	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	5.14e-05	0.00039	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	5.14e-05	0.00039	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2RA—type 1 diabetes mellitus	5.08e-05	0.000386	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-A—type 1 diabetes mellitus	5.02e-05	0.000382	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	4.89e-05	0.000372	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	4.89e-05	0.000372	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERBB3—type 1 diabetes mellitus	4.84e-05	0.000368	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CRP—type 1 diabetes mellitus	4.79e-05	0.000364	CbGpPWpGaD
Niclosamide—STAT3—Disease—CCR5—type 1 diabetes mellitus	4.76e-05	0.000362	CbGpPWpGaD
Niclosamide—STAT3—Disease—HLA-A—type 1 diabetes mellitus	4.64e-05	0.000352	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GCG—type 1 diabetes mellitus	4.61e-05	0.00035	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DRB1—type 1 diabetes mellitus	4.59e-05	0.000349	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.44e-05	0.000337	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EGFR—type 1 diabetes mellitus	4.43e-05	0.000337	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.31e-05	0.000328	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.3e-05	0.000327	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD80—type 1 diabetes mellitus	4.24e-05	0.000322	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—type 1 diabetes mellitus	4.22e-05	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS2—type 1 diabetes mellitus	4.03e-05	0.000307	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD80—type 1 diabetes mellitus	3.91e-05	0.000298	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.9e-05	0.000297	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CD86—type 1 diabetes mellitus	3.76e-05	0.000286	CbGpPWpGaD
Niclosamide—STAT3—Disease—INS—type 1 diabetes mellitus	3.7e-05	0.000281	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TYK2—type 1 diabetes mellitus	3.58e-05	0.000272	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.57e-05	0.000271	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—type 1 diabetes mellitus	3.4e-05	0.000259	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.39e-05	0.000258	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNG—type 1 diabetes mellitus	3.35e-05	0.000255	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.33e-05	0.000253	CbGpPWpGaD
Niclosamide—STAT3—Disease—TYK2—type 1 diabetes mellitus	3.3e-05	0.000251	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.28e-05	0.00025	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS3—type 1 diabetes mellitus	3.24e-05	0.000247	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD4—type 1 diabetes mellitus	3.24e-05	0.000246	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	3.21e-05	0.000244	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1B—type 1 diabetes mellitus	2.99e-05	0.000227	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD4—type 1 diabetes mellitus	2.99e-05	0.000227	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—type 1 diabetes mellitus	2.98e-05	0.000226	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	2.81e-05	0.000214	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	2.75e-05	0.000209	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CD80—type 1 diabetes mellitus	2.74e-05	0.000208	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	2.65e-05	0.000201	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INS—type 1 diabetes mellitus	2.59e-05	0.000197	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.51e-05	0.00019	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	2.4e-05	0.000183	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.31e-05	0.000176	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	2.29e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGFR—type 1 diabetes mellitus	2.28e-05	0.000173	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.27e-05	0.000173	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	2.26e-05	0.000172	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGFR—type 1 diabetes mellitus	2.1e-05	0.00016	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	1.96e-05	0.000149	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.93e-05	0.000147	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.93e-05	0.000146	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	1.81e-05	0.000138	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—type 1 diabetes mellitus	1.75e-05	0.000133	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—type 1 diabetes mellitus	1.62e-05	0.000123	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	1.55e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.53e-05	0.000116	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.47e-05	0.000112	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.44e-05	0.000109	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.43e-05	0.000109	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.41e-05	0.000107	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.31e-05	9.94e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.3e-05	9.85e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.23e-05	9.35e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.22e-05	9.3e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.2e-05	9.13e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.13e-05	8.6e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.12e-05	8.51e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.11e-05	8.41e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	9.57e-06	7.27e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	9.48e-06	7.21e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	8.1e-06	6.16e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	6.29e-06	4.78e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.77e-06	4.39e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	5.52e-06	4.19e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	5.38e-06	4.09e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	4.93e-06	3.75e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	4.72e-06	3.58e-05	CbGpPWpGaD
